Dean, James
Fowler, Stephen J.
Singh, Dave
Beech, Augusta
Funding for this research was provided by:
AstraZeneca
Chiesi Farmaceutici
Article History
Received: 18 June 2024
Accepted: 9 September 2024
First Online: 3 October 2024
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki, and the study protocol was reviewed and approved by local Ethics Committees (16/NW/0836; 18/NI/0194). Written informed consent was obtained from all subjects involved in the study.
: Not applicable.
: JD; the author declares that they have no competing interests. SJF; the author declares that they have no competing interests. DS has received personal fees from Aerogen, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, CSL Behring, Epidendo, Genentech, GlaxoSmithKline, Glenmark, Gossamerbio, Kinaset, Menarini, Novartis, Orion, Pulmatrix, Sanofi, Synairgen, Teva, Theravance and Verona. AB; the author declares that they have no competing interests.